Spectrum and functional validation of PSMB5 mutations in multiple myeloma-Reference-Cited by-同舟云学术

Spectrum and functional validation of PSMB5 mutations in multiple myeloma

Published:2018-07-19 Issue:2 Volume:33 Page:447-456
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Barrio Santiago,Stühmer Thorsten,Da-Viá Matteo,Barrio-Garcia Clara,Lehners Nicola^ORCID,Besse Andrej,Cuenca Isabel,Garitano-Trojaola Andoni,Fink Severin,Leich Ellen^ORCID,Chatterjee Manik,Driessen Christoph,Martinez-Lopez Joaquin,Rosenwald Andreas,Beckmann Roland,Bargou Ralf C.,Braggio Esteban,Stewart A. Keith,Raab Marc S.,Einsele Hermann,Kortüm K. Martin

Funder

IZKF Z-3R/1, University of Würzburg, Germany

Deutsche Forschungsgemeinschaft (German Research Foundation)

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/s41375-018-0216-8.pdf

Reference37 articles.

1. Bolli N, Avet-Loiseau H, Wedge DC, Van Loo P, Alexandrov LB, Martincorena I, et al. Heterogeneity of genomic evolution and mutational profiles in multiple myeloma. Nat Commun. 2014;5:2997.

2. Lohr JG, Stojanov P, Carter SL, Cruz-Gordillo P, Lawrence MS, Auclair D, et al. Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy. Cancer Cell. 2014;25:91–101.